2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | 42.209 | 72.212 | 91.127 | 79.138 | 83.721 | 116.921 |
Total Income - EUR | - | - | - | - | 42.209 | 72.212 | 91.127 | 79.138 | 83.721 | 116.921 |
Total Expenses - EUR | - | - | - | - | 46.309 | 66.873 | 79.128 | 76.709 | 81.346 | 112.228 |
Gross Profit/Loss - EUR | - | - | - | - | -4.100 | 5.339 | 12.000 | 2.429 | 2.375 | 4.693 |
Net Profit/Loss - EUR | - | - | - | - | -4.522 | 4.224 | 10.721 | 1.727 | 1.083 | 3.857 |
Employees | - | - | - | - | 2 | 1 | 1 | 1 | 2 | 1 |
Check the financial reports for the company - Bio Chris Pharma S.r.l.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 292 | 529 | 824 | 932 | 979 | - | - | - | - |
Current Assets | - | - | - | - | 5.007 | 7.084 | 11.655 | 10.178 | 10.253 | 23.095 |
Inventories | - | - | - | - | 4.378 | 6.175 | 7.677 | 7.972 | 8.393 | 18.486 |
Receivables | - | - | - | - | 0 | 0 | 1.244 | 1.182 | 1.108 | 2.952 |
Cash | - | - | - | - | 629 | 909 | 2.735 | 1.024 | 751 | 1.658 |
Shareholders Funds | - | - | - | - | -4.479 | -169 | 10.555 | 6.622 | 1.328 | 5.138 |
Social Capital | - | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | - | - | 10.478 | 8.243 | 2.110 | 4.085 | 9.216 | 17.957 |
Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4729 - 4729" | |||||||||
CAEN Financial Year | 4729 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.